Ftse Mib
34.490,71
0,07%
DAX
18.693,37
0,04%
S&P 500
5.304,72
0,70%
NASDAQ
16.920,79
1,10%
Bitcoin
69.069,13
-0,29%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Tetraphase Pharmaceuticals Inc (TTPH) Tetraphase Pharmaceuticals Inc (TTPH) Notizie

TTPH

Tetraphase Pharmaceuticals (TTPH)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TTPH
DataOraFonteTitoloSimboloCompagnia
31/08/202021:20Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
31/08/202012:07Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
25/08/202012:02Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
25/08/202012:01Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
11/08/202020:56Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
31/07/202012:37Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
29/07/202023:25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
29/07/202015:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
29/07/202012:02Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
29/07/202012:01Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
28/07/202022:15GlobeNewswire Inc.La Jolla Pharmaceutical Company Announces the Closing of Acquisition of Tetraphase Pharmaceuticals, Inc.NASDAQ:TTPHTetraphase Pharmaceuticals Inc
29/06/202015:50Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
29/06/202015:31Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
24/06/202014:01Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
24/06/202013:47Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
24/06/202013:30GlobeNewswire Inc.La Jolla Pharmaceutical Company to Acquire Tetraphase Pharmaceuticals, Inc.NASDAQ:TTPHTetraphase Pharmaceuticals Inc
22/06/202012:00Business WireTetraphase Announces Receipt of Proposal from La Jolla Pharmaceutical Company, Determination of Superior Offer & Notice to Me...NASDAQ:TTPHTetraphase Pharmaceuticals Inc
04/06/202015:22Business WireMelinta Therapeutics to Acquire Tetraphase PharmaceuticalsNASDAQ:TTPHTetraphase Pharmaceuticals Inc
04/06/202000:50PR Newswire (US)AcelRx Pharmaceuticals Announces It Will Not Further Revise Its Offer to Acquire TetraphaseNASDAQ:TTPHTetraphase Pharmaceuticals Inc
01/06/202023:12Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
01/06/202022:51Business WireTetraphase Announces Receipt of Amended Melinta Proposal, Determination of Superior Offer and Notice to AcelRxNASDAQ:TTPHTetraphase Pharmaceuticals Inc
29/05/202014:43Business WireTetraphase Announces Second Amendment to Merger Agreement with AcelRx Pharmaceuticals for Increased ConsiderationNASDAQ:TTPHTetraphase Pharmaceuticals Inc
29/05/202014:30PR Newswire (US)AcelRx Pharmaceuticals Announces Revised Merger Agreement with TetraphaseNASDAQ:TTPHTetraphase Pharmaceuticals Inc
27/05/202015:25Business WireTetraphase Announces Amendment to Merger Agreement with AcelRx Pharmaceuticals for Increased ConsiderationNASDAQ:TTPHTetraphase Pharmaceuticals Inc
22/05/202003:55Business WireTetraphase Announces Determination of Superior Offer and Notice to AcelRxNASDAQ:TTPHTetraphase Pharmaceuticals Inc
07/05/202022:15Business WireTetraphase Pharmaceuticals Reports First Quarter 2020 Financial Results and Highlights Recent Corporate DevelopmentsNASDAQ:TTPHTetraphase Pharmaceuticals Inc
07/05/202022:04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
24/04/202022:09Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
21/04/202003:56PR Newswire (US)SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers; Are Shareholders Getting a Fair Deal?NASDAQ:TTPHTetraphase Pharmaceuticals Inc
18/03/202018:52PR Newswire (US)Moore Kuehn Encourages DLPH, CSFL, TTPH, and FSCT Investors to Contact Law FirmNASDAQ:TTPHTetraphase Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TTPH

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
TIT
Telecom Italia
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
STMMI
ST Microelectronics
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
TEN
Tenaris
BIT
RACE
Ferrari NV
BIT
SPM
Saipem
BIT
BAMI
Banco BPM
BIT
PRY
Prysmian
BIT
BPE
Bper Banca
BIT
TITR
Telecom Italia
BIT
SRG
Snam
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network